These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33417506)

  • 21. Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0.
    Girgis A; Durcinoska I; Gerges M; Kaadan N; Arnold A; Descallar J; Delaney GP;
    BMC Cancer; 2018 Aug; 18(1):845. PubMed ID: 30139331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: results from a phase III randomized trial.
    Cella D; Li JZ; Cappelleri JC; Bushmakin A; Charbonneau C; Kim ST; Chen I; Motzer RJ
    J Clin Oncol; 2008 Aug; 26(22):3763-9. PubMed ID: 18669464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
    Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
    Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial.
    Takano T; Matsuda A; Ishizuka N; Ozaki Y; Suyama K; Tanabe Y; Miura Y; Matsushima E
    BMC Cancer; 2021 May; 21(1):588. PubMed ID: 34022838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use and Effects of Electronic Health Tools for Patient Self-Monitoring and Reporting of Outcomes Following Medication Use: Systematic Review.
    Lancaster K; Abuzour A; Khaira M; Mathers A; Chan A; Bui V; Lok A; Thabane L; Dolovich L
    J Med Internet Res; 2018 Dec; 20(12):e294. PubMed ID: 30563822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial.
    Hurvitz SA; Quek RGW; Turner NC; Telli ML; Rugo HS; Mailliez A; Ettl J; Grischke E; Mina LA; Balmaña J; Fasching PA; Bhattacharyya H; Hannah AL; Robson ME; Wardley AM
    Eur J Cancer; 2018 Nov; 104():160-168. PubMed ID: 30359909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An eHealth Diary and Symptom-Tracking Tool Combined With Person-Centered Care for Improving Self-Efficacy After a Diagnosis of Acute Coronary Syndrome: A Substudy of a Randomized Controlled Trial.
    Wolf A; Fors A; Ulin K; Thorn J; Swedberg K; Ekman I
    J Med Internet Res; 2016 Feb; 18(2):e40. PubMed ID: 26907584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery.
    Avery KNL; Richards HS; Portal A; Reed T; Harding R; Carter R; Bamforth L; Absolom K; O'Connell Francischetto E; Velikova G; Blazeby JM
    BMC Cancer; 2019 May; 19(1):463. PubMed ID: 31101017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
    Meyers FJ; Linder J; Beckett L; Christensen S; Blais J; Gandara DR
    J Pain Symptom Manage; 2004 Dec; 28(6):548-56. PubMed ID: 15589080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to a patient-centered, Web-based intervention for managing cancer symptom and quality of life issues: impact on symptom distress.
    Berry DL; Blonquist TM; Patel RA; Halpenny B; McReynolds J
    J Med Internet Res; 2015 Jun; 17(6):e136. PubMed ID: 26041682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of weekly symptom telemonitoring in advanced lung cancer.
    Yount SE; Rothrock N; Bass M; Beaumont JL; Pach D; Lad T; Patel J; Corona M; Weiland R; Del Ciello K; Cella D
    J Pain Symptom Manage; 2014 Jun; 47(6):973-89. PubMed ID: 24210705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
    Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
    J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial.
    Mijwel S; Backman M; Bolam KA; Jervaeus A; Sundberg CJ; Margolin S; Browall M; Rundqvist H; Wengström Y
    Breast Cancer Res Treat; 2018 Feb; 168(1):79-93. PubMed ID: 29139007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
    Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
    Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.